A Study of the Association Between Tobacco Smoking and Bipolar Affective Disorder
NCT00741299 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2012-07-26
Summary
The purpose of this study is to examine whether tobacco smoking is associated with bipolar affective disorder (severity of depressive and manic symptoms, presence of psychotic symptoms, history of a suicide attempts and other clinical features.)
Conditions
Sponsors & Collaborators
-
Tirat Carmel Mental Health Center
lead OTHER_GOV
Principal Investigators
-
Anatoly Kreinin, MD, PHD · B. Rappaport Faculty of Medicine, Technion, Haifa
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-08-31
- Primary Completion
- 2009-07-31
- Completion
- 2009-09-30
Countries
- Israel
More Related Trials
-
Tryptophan Depletion in Acute Mania
NCT00192725 ·Status: COMPLETED ·Phase: NA
-
Risk Factors for Development of Rapid Cycling in Bipolar Disorder Patients
NCT01992302 ·Status: COMPLETED
-
Prospective Metabolic Monitoring of Youth and Adults With Bipolar Disorder
NCT01282281 ·Status: COMPLETED
-
Depressive Symptoms in Acute Manic Episode
NCT00690248 ·Status: COMPLETED
-
Does Bipolar Disease Program (BDP) Intervention Improve Long Term Manic and Depressive Symptoms.
NCT00007761 ·Status: COMPLETED ·Phase: PHASE3
-
Cannabinoids in Bipolar Affective Disorder
NCT00397605 ·Status: WITHDRAWN ·Phase: NA
-
Quetiapine in Patients With Bipolar and Alcohol Abuse/Dependence
NCT00223249 ·Status: COMPLETED ·Phase: PHASE4
-
Epigenetic and Neurochemical Correlates of Bipolar Disorder
NCT06829316 ·Status: NOT_YET_RECRUITING
-
An Epidemiological Registry Study to Evaluate Clinical Practice Treatment in Patients With Bipolar Disorder
NCT01455961 ·Status: COMPLETED
-
Cannabidiol as an Adjunctive Treatment for Bipolar Depression
NCT03310593 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Neurophysiologic Changes in Patients With Bipolar Depression
NCT01213121 ·Status: UNKNOWN ·Phase: PHASE4
-
Cannabidiol for Bipolar Depression (CBD-BD)
NCT05867849 ·Status: RECRUITING ·Phase: PHASE3
-
Treatment for Bipolar Depression: Acute & Prophylactic Efficacy With Citalopram
NCT00562861 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Pain, Sleep Quality, Eating Habits and Physical Activity Level in Patients With Bipolar Disorder
NCT06954350 ·Status: ENROLLING_BY_INVITATION
-
Treatment of Alcohol Dependence and Comorbid Bipolar Disorder
NCT01015586 ·Status: COMPLETED ·Phase: PHASE4
-
Parents With Bipolar Disorder: Relationship of Adaptation to Own Illness With Risk Perception and Coping With Perceived Risk to a Child
NCT01012180 ·Status: COMPLETED
-
Identification of Predictive Biomarkers of Mood Relapses in Patients With Bipolar Disorder
NCT04703972 ·Status: UNKNOWN ·Phase: NA
-
Adapting the Bipolar Care Model for Chronic Care Management in Community-based Health Care Sites
NCT00747201 ·Status: COMPLETED ·Phase: NA
-
Intervention for Comorbid Substance Use and Bipolar Disorders
NCT04202393 ·Status: COMPLETED ·Phase: NA
-
Bipolar Disorder and Oxidative Stress Injury Mechanism - Clinical Big Data Analysis Based on Machine Learning
NCT03949218 ·Status: COMPLETED
-
Understanding Treatment Adherence Among Individuals With Bipolar Disorder
NCT00183495 ·Status: COMPLETED
-
Evaluation of Brain MRI and Clinical Characteristics of Adolescents With Bipolar Disorder and Children of Parents With Bipolar Disorder
NCT01678989 ·Status: UNKNOWN
-
A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
NCT01072929 ·Status: COMPLETED ·Phase: PHASE3
-
Brexpiprazole Treatment for Bipolar I Depression
NCT04569448 ·Status: RECRUITING ·Phase: PHASE3
-
Acamprosate vs. Placebo in Bipolar Alcoholics
NCT00466661 ·Status: COMPLETED ·Phase: PHASE4